[ad_1]
An international group of scientists announced the completion of the clinical trial phase of the new experimental HIV vaccine (HIV). This is reported by the medical journal The Lancet. The long-term research has been successful: the tests confirm the safety of the drug as well as the presence of an immune response in the body.
The drug was administered to volunteers on several occasions: from the experiment, then to the 12th, 28th and 48th weeks. And the first thing doctors have made clear is that the drug is completely safe for healthy people: only some volunteers have experienced pain, dizziness and mild discomfort. Another surprise was waiting scientists that they are studying the blood of volunteers: those who received the vaccine have significantly increased the number of antibodies against viral proteins and increased immunity
In parallel, the drug was tested on 72 macaques. The vaccine should protect animals against infection with the artificially generated SHIV-SF162P3 virus containing HIV genes and monkeys immunodeficiency virus. It turns out that among the vaccinated macaques, 67% did not succumb to the disease. (19659003) Translation and Editing: Blitz
[ad_2]
Source link
